Mechanisms and Regulation of Gene Expression by Androgen Receptor in Prostate Cancer
Abstract
Our general objective is to use completely defined cell-free transcription systems both to identify novel AR-associated cofactors and to investigate the mechanism of action of AR and both novel and previously identified candidate coactivators. In an attempt to isolate cofactors capable of influencing AR transcriptional activity, we used an immunoprecipitation method and identified a 44-kDa protein, designated as p44, as a new AR-interacting protein. P44 interacts with AR in the nucleus and with an androgen-regulated homeobox protein (NKx3. 1) in the cytoplasm of LNCaP cells. Transient transfection assay revealed that p44 enhances AR-, glucocorticoid receptor-, and progesterone receptor- dependent transcription but not estrogen receptor- or thyroid hormone receptor-dependent transcription. P44 was recruited onto the promoter of the prostate-specific antigen gene in the presence of the androgen in LNCaP cells. P44 exists as a multiprotein complex in the nucleus of HeLa cells. This complex, but not p44 alone, enhances AR-driven transcription in vitro in a cell-free transcriptional system and contains the protein arginine methyltransferase 5 (PRMT5), which acts synergistically with p44 to enhance AR-driven gene expression in a methyltransferase-independent manner. Our data suggest that a novel mechanism by which the protein arginine methyltransferase is involved in the control of AR-driven transcription. P44 expression is dramatically enhanced in prostate cancer tissue when compared with adjacent benign prostate tissue.
Document Details
- Document Type
- Technical Report
- Publication Date
- Jul 01, 2003
- Accession Number
- ADA417936
Entities
People
- Zhengxin Wang
Organizations
- The University of Texas MD Anderson Cancer Center